ICCTR | About Us
What is ICCTR?
The Boston Children’s Hospital Institutional Centers for Clinical and Translational Research (ICCTR, formerly the CRC) supports investigators in the design, conduct and reporting of clinical and translational studies, along with educating the diverse Boston Children's research community on clinical research best practices.
The ICCTR is made up of three distinct centers.
Biostats & Research Design Center
TheBiostats and Research Design Centerprovides biostatistical and methodological expertise, and scientific leadership through collaborative relationships with investigators, as well as educational offerings.
Clinical Research Operations Center
The clinical research professionals of the Clinical Research Operations Center provide exceptional support and service to investigators conducting clinical research studies at Boston Children’s Hospital. The Center supports a full spectrum of studies from high-risk interventional trials with experimental therapeutics, and experimental drugs and devices, to the minimal-risk observational clinical research studies
Translational Research Program
TheTranslational Research Program (TRP)aims to stimulate and facilitate the development of preclinical and, ultimately, human translational trials to improve the care of children with serious conditions.
Office of Investigator Outreach
TheOffice of Investigator Outreachfocuses is on supporting early-career investigators. We provide a single contact point to navigate research resources, educational offerings and career development opportunities at Boston Children’s as well as Harvard Catalyst.
Supporting researchers
Support is provided to investigators at all stages of protocol development and study conduct in order to ensure that research is designed in such a way to maximize benefits and minimize risks to participants in clinical research studies. Partial funding for these services is from theHarvard Catalyst, an NIH-funded Harvard Clinical and Translational Sciences Award (CTSA), which provides increased opportunities for investigator education and collaborations across the Harvard teaching hospitals.
Citing Harvard Catalyst
The National Institutes of Health requires investigators who use Harvard Catalyst resources and services (e.g., consulting services, Clinical Research Center) or receive funding through Harvard Catalyst (e.g., pilot grants, KL2, CMeRIT awards)acknowledge that support in publications and posters, and comply with NIH Public Access Policy.
ICCTR Leadership
David A. Williams, MD
Chief, Division of Hematology/Oncology, Boston Children’s Hospital; Associate Chairman, Department of Pediatric Oncology, Dana-Farber Cancer Institute; Institute Physician Leland Fikes Professor of Pediatrics, Harvard Medical School
Andrew Place, MD, PhD
Co-Director, Hematologic Malignancy Center (Clinical Service & Clinical Research); Chief Medical Officer, Institutional Centers for Clinical and Translational Research (ICCTR); Associate Director, Developmental Therapeutics; Senior Physician 哈佛医学院的儿科医学助理教授School
Hernan Santana, MS
Senior Director, Institutional Centers for Clinical and Translational Research (ICCTR)
辛迪·威廉姆斯,DNP, MSN, RN, NE-BC PNP型
Nursing Director, Experimental Therapeutics Unit; Co-Director, ICCTR Study Operations Center; Director, Office of Research Regulatory Support, Education, and Quality
Edie Weller, PhD
Director of ICCTR Biostatistics and Research Design Center Associate Professor of Pediatrics, Harvard Medical School
Michael Monuteaux, ScD
Associate Director of ICCTR Biostatistics and Research Design Center, Senior Epidemiologist and Biostatistician Associate Professor of Pediatrics, Harvard Medical School
Mustafa Sahin, MD, PhD
Director, Translational Neuroscience Center; Director, Translational Research Program; Rosamund Stone Zander Chair Professor of Neurology, Harvard Medical School
Judith Fleming, PhD
Associate Director, Translational Research Program, Research Administration
